Literature DB >> 30719815

Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.

Veerawat Nomsawadi1, Rungroj Krittayaphong2.   

Abstract

BACKGROUND: Presence of left ventricular hypertrophy (LVH) increases the risk for cardiovascular event. Many electrocardiographic (ECG) criteria can be used to diagnose LVH; however, high body mass index (BMI) may reduce ECG amplitudes.The aim of this study was to investigate the diagnostic performance of ECG criteria for diagnosing LVH among various BMI groups compared to diagnosis by cardiac magnetic resonance (CMR) imaging.
METHODS: Patients who were referred for CMR were enrolled. CMR and ECG were performed on the same day. Left ventricular function, volume, and mass were calculated from CMR. Standard ECG criteria were measured, including: Cornell voltage, Cornell product, Romhilt-Estes point score system, Sokolow-Lyon index, and Sokolow-Lyon-Rappaport index. Diagnostic performance of each ECG criterion was calculated and analyzed in the following four BMI groups: underweight (<18.5 kg/m2 ), normal (18.5-22.9 kg/m2 ), overweight (23-24.9 kg/m2 ), and obese (≥25 kg/m2 ).
RESULTS: Of the 1,882 patients that were included, 67 were underweight, 459 were normal weight, 434 were overweight, and 922 were obese. LVH was diagnosed in 34 (50.7%) underweight, 144 (31.4%) normal weight, 100 (23.0%) overweight, and 181 (19.6%) obese patients. Overall specificity of ECG was high (0.89-0.95), and overall sensitivity was low (0.25-0.37). The specificity of each ECG criterion was similar among BMI groups; however, the sensitivity of ECG criteria demonstrated a decreasing trend in the higher BMI groups.
CONCLUSION: All ECG criteria demonstrated relatively high specificity and relatively low sensitivity. Although the specificity across groups remained similar, higher BMI was found to be associated with decreased sensitivity.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  body mass index; diagnostic performance; electrocardiography; left ventricular hypertrophy; magnetic resonance imaging

Mesh:

Year:  2019        PMID: 30719815      PMCID: PMC6931489          DOI: 10.1111/anec.12635

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  34 in total

1.  Left ventricular mass change during treatment and outcome in patients with essential hypertension.

Authors:  Michael J Koren; Roy J Ulin; Andrew T Koren; John H Laragh; Richard B Devereux
Journal:  Am J Hypertens       Date:  2002-12       Impact factor: 2.689

2.  Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.

Authors:  Liangdi Xie; Zili Wang
Journal:  Hellenic J Cardiol       Date:  2010 Sep-Oct

3.  Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.

Authors:  P M Okin; S Jern; R B Devereux; S E Kjeldsen; B Dahlöf
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

4.  A critical appraisal of the electrocardiographic criteria for the diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; K E Bove; R J Norris; E Conyers; S Conradi; D T Rowlands; R C Scott
Journal:  Circulation       Date:  1969-08       Impact factor: 29.690

5.  Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity.

Authors:  J E Norman; D Levy
Journal:  J Electrocardiol       Date:  1996       Impact factor: 1.438

6.  Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction.

Authors:  Todd T Schlegel; Walter B Kulecz; Alan H Feiveson; E Carl Greco; Jude L DePalma; Vito Starc; Bojan Vrtovec; M Atiar Rahman; Michael W Bungo; Matthew J Hayat; Terry Bauch; Reynolds Delgado; Stafford G Warren; Tulio Núñez-Medina; Rubén Medina; Diego Jugo; Håkan Arheden; Olle Pahlm
Journal:  BMC Cardiovasc Disord       Date:  2010-06-16       Impact factor: 2.298

7.  Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product.

Authors:  T J Molloy; P M Okin; R B Devereux; P Kligfield
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

8.  Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.

Authors:  P N Casale; R B Devereux; P Kligfield; R R Eisenberg; D H Miller; B S Chaudhary; M C Phillips
Journal:  J Am Coll Cardiol       Date:  1985-09       Impact factor: 24.094

9.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.

Authors:  J V Durnin; J Womersley
Journal:  Br J Nutr       Date:  1974-07       Impact factor: 3.718

10.  Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study.

Authors:  M Bikkina; D Levy; J C Evans; M G Larson; E J Benjamin; P A Wolf; W P Castelli
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

View more
  2 in total

1.  Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy.

Authors:  Hesham Afify; Ho Lim Lee; Elsayed Z Soliman; Matthew J Singleton
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

2.  Visceral fat level correction of the left ventricular hypertrophy electrocardiographic criteria.

Authors:  Szymon Salamaga; Franciszek Dydowicz; Agnieszka Turowska; Iwona Juszczyk; Mateusz Matyjasek; Katarzyna Kostka-Jeziorny; Ludwina Szczepaniak-Chicheł; Andrzej Tykarski; Paweł Uruski
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-06-11       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.